Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1356 | 2606 | 31.1 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
335 | 17284 | BLADDER CANCER//CYSTECTOMY//URINARY DIVERSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BLADDER PRESERVATION | Author keyword | 144 | 93% | 2% | 54 |
2 | BLADDER CANCER | Author keyword | 87 | 12% | 27% | 693 |
3 | CYSTECTOMY | Author keyword | 73 | 22% | 11% | 288 |
4 | RADICAL CYSTECTOMY | Author keyword | 51 | 28% | 6% | 157 |
5 | MUSCLE INVASIVE BLADDER CANCER | Author keyword | 40 | 58% | 2% | 46 |
6 | INVASIVE BLADDER CANCER | Author keyword | 32 | 55% | 2% | 41 |
7 | UROTHELIAL CANCER | Author keyword | 30 | 27% | 4% | 92 |
8 | ADVANCED UROTHELIAL CARCINOMA | Author keyword | 24 | 82% | 1% | 14 |
9 | UROTHELIAL CARCINOMA | Author keyword | 23 | 14% | 6% | 151 |
10 | ADVANCED BLADDER CANCER | Author keyword | 21 | 78% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BLADDER PRESERVATION | 144 | 93% | 2% | 54 | Search BLADDER+PRESERVATION | Search BLADDER+PRESERVATION |
2 | BLADDER CANCER | 87 | 12% | 27% | 693 | Search BLADDER+CANCER | Search BLADDER+CANCER |
3 | CYSTECTOMY | 73 | 22% | 11% | 288 | Search CYSTECTOMY | Search CYSTECTOMY |
4 | RADICAL CYSTECTOMY | 51 | 28% | 6% | 157 | Search RADICAL+CYSTECTOMY | Search RADICAL+CYSTECTOMY |
5 | MUSCLE INVASIVE BLADDER CANCER | 40 | 58% | 2% | 46 | Search MUSCLE+INVASIVE+BLADDER+CANCER | Search MUSCLE+INVASIVE+BLADDER+CANCER |
6 | INVASIVE BLADDER CANCER | 32 | 55% | 2% | 41 | Search INVASIVE+BLADDER+CANCER | Search INVASIVE+BLADDER+CANCER |
7 | UROTHELIAL CANCER | 30 | 27% | 4% | 92 | Search UROTHELIAL+CANCER | Search UROTHELIAL+CANCER |
8 | ADVANCED UROTHELIAL CARCINOMA | 24 | 82% | 1% | 14 | Search ADVANCED+UROTHELIAL+CARCINOMA | Search ADVANCED+UROTHELIAL+CARCINOMA |
9 | UROTHELIAL CARCINOMA | 23 | 14% | 6% | 151 | Search UROTHELIAL+CARCINOMA | Search UROTHELIAL+CARCINOMA |
10 | ADVANCED BLADDER CANCER | 21 | 78% | 1% | 14 | Search ADVANCED+BLADDER+CANCER | Search ADVANCED+BLADDER+CANCER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | M VAC METHOTREXATE | 329 | 86% | 6% | 165 |
2 | RADICAL CYSTECTOMY | 229 | 31% | 24% | 627 |
3 | TRANSITIONAL CELL CARCINOMA | 210 | 18% | 42% | 1090 |
4 | SELECTIVE ORGAN PRESERVATION | 168 | 89% | 3% | 75 |
5 | GEMCITABINE PLUS CISPLATIN | 139 | 74% | 4% | 102 |
6 | ADVANCED UROTHELIAL CANCER | 114 | 83% | 2% | 64 |
7 | COMBINED MODALITY PROGRAM | 109 | 89% | 2% | 49 |
8 | ADVANCED UROTHELIAL CARCINOMA | 102 | 83% | 2% | 58 |
9 | M VAC | 94 | 77% | 2% | 64 |
10 | VINBLASTINE | 90 | 19% | 17% | 436 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials | 2014 | 32 | 27 | 74% |
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma-Neoadjuvant and Adjuvant Settings | 2013 | 33 | 51 | 98% |
Bladder Cancer | 2013 | 43 | 84 | 63% |
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder | 2013 | 51 | 100 | 50% |
Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data | 2005 | 238 | 7 | 71% |
Bladder cancer | 2009 | 280 | 101 | 39% |
A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer | 2012 | 49 | 52 | 90% |
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) | 2015 | 1 | 37 | 95% |
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review | 2014 | 10 | 112 | 89% |
Organ-sparing surgery in urology: partial cystectomy | 2015 | 1 | 11 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PIO XI | 9 | 83% | 0.2% | 5 |
2 | LBI ACR VIENNA CTO | 6 | 80% | 0.2% | 4 |
3 | GENITOURINARY ONCOL SERV | 4 | 10% | 1.5% | 38 |
4 | ACR ITR CEADDP | 4 | 75% | 0.1% | 3 |
5 | CARITAS ST JOSEF MED | 4 | 18% | 0.7% | 18 |
6 | WTZE EV | 3 | 100% | 0.1% | 3 |
7 | KIMMEL PROSTATE UROL CANC | 3 | 50% | 0.2% | 4 |
8 | MCKESSON SPECIALTY HLTH | 3 | 42% | 0.2% | 5 |
9 | CLIN EPIDEMIOL TRIALS ORG UNIT | 2 | 38% | 0.2% | 5 |
10 | GENITOURINARY ONCOL UNIT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000289102 | CYSTECTOMY//RADICAL CYSTECTOMY//LAPAROSCOPIC RADICAL CYSTECTOMY |
2 | 0.0000189027 | PROSTATE SPARING//CYSTOPROSTATECTOMY//RADICAL CYSTOPROSTATECTOMY |
3 | 0.0000110948 | FGFR3//GENES P53//DBCCR1 |
4 | 0.0000105159 | VIRTUAL CYSTOSCOPY//BLADDER NEOPLASMS STAGING//BLADDER NEOPLASMS CT |
5 | 0.0000090184 | SUPERFICIAL BLADDER CANCER//NON MUSCLE INVASIVE BLADDER CANCER//BACILLUS CALMETTE GUERIN |
6 | 0.0000075970 | MICROPAPILLARY CARCINOMA//INVASIVE MICROPAPILLARY CARCINOMA//MICROPAPILLARY |
7 | 0.0000070172 | NEPHROURETERECTOMY//UPPER URINARY TRACT//UPPER TRACT UROTHELIAL CARCINOMA |
8 | 0.0000052568 | WHO ABORAT FOOD NUTR POLICIES//STUDIES MED PROGRAMS SERV//COMPLEX GENET |
9 | 0.0000040372 | PELVIC LYMPH NODE DISSECTION//EXTENDED PELVIC LYMPH NODE DISSECTION//LYMPH NODE INVASION |
10 | 0.0000038947 | URINARY DIVERSION//URINARY RESERVOIRS CONTINENT//ENTEROCYSTOPLASTY |